Prospective Research Assessment in Multiple Myeloma: An Observational Evaluation

The purpose of this study is to assess the clinical effectiveness of all approved multiple myeloma (MM) therapies in the newly-diagnosed (NDMM) and the relapsed/refractory MM (RRMM) settings in real-world clinical practice.

For more information please visit https://clinicaltrials.gov/study/NCT01838512

Interested in Volunteering for the Study?

If you would like more information about this study, please call us at 318-212-8671 .